Last reviewed · How we verify
Qishenyiqi dropping pills
Qishenyiqi dropping pills is a traditional Chinese medicine formulation that enhances cardiac function and improves blood circulation to support heart health.
Qishenyiqi dropping pills is a traditional Chinese medicine formulation that enhances cardiac function and improves blood circulation to support heart health. Used for Angina pectoris, Heart failure, Cardiac insufficiency.
At a glance
| Generic name | Qishenyiqi dropping pills |
|---|---|
| Also known as | QSYQ |
| Sponsor | Chinese Academy of Medical Sciences, Fuwai Hospital |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This herbal combination works by invigorating qi (vital energy) and blood flow, particularly targeting cardiac and circulatory function. It is used in traditional Chinese medicine to strengthen heart contractility and improve microcirculation, thereby reducing symptoms associated with cardiac insufficiency and angina.
Approved indications
- Angina pectoris
- Heart failure
- Cardiac insufficiency
Common side effects
Key clinical trials
- Pre-trial of Clinical Trial of Traditional Chinese Medicine Treatment for Elderly Patients With Coronary Heart Disease Who Are Still Symptomatic After Optimal Medical Treatment (PHASE4)
- Cohort Study on Treatment of Cardiovascular Diseases With Traditional Chinese Medicine
- Retrospective Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
- The Study of Qishenyiqi Drop Pills in Improving the Prognosis of Heart Failure Patients (PHASE4)
- Clinical Study on Adjuvant Treatment of Coronary Heart Disease Angina Pectoris With Chinese Patent Medicine
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: